![Baicalein Delays H2O2-Induced Astrocytic Senescence through Inhibition of Senescence-Associated Secretory Phenotype (SASP), Suppression of JAK2/STAT1/NF-κB Pathway, and Regulation of Leucine Metabolism | ACS Chemical Neuroscience Baicalein Delays H2O2-Induced Astrocytic Senescence through Inhibition of Senescence-Associated Secretory Phenotype (SASP), Suppression of JAK2/STAT1/NF-κB Pathway, and Regulation of Leucine Metabolism | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/acschemneuro.1c00024/asset/images/large/cn1c00024_0013.jpeg)
Baicalein Delays H2O2-Induced Astrocytic Senescence through Inhibition of Senescence-Associated Secretory Phenotype (SASP), Suppression of JAK2/STAT1/NF-κB Pathway, and Regulation of Leucine Metabolism | ACS Chemical Neuroscience
![Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C+ NK cells to target myeloid leukemia - ScienceDirect Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C+ NK cells to target myeloid leukemia - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525001621003245-fx1.jpg)
Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C+ NK cells to target myeloid leukemia - ScienceDirect
![Frontiers | Characterizing the Dysfunctional NK Cell: Assessing the Clinical Relevance of Exhaustion, Anergy, and Senescence Frontiers | Characterizing the Dysfunctional NK Cell: Assessing the Clinical Relevance of Exhaustion, Anergy, and Senescence](https://www.frontiersin.org/files/Articles/519676/fcimb-10-00049-HTML/image_m/fcimb-10-00049-g001.jpg)
Frontiers | Characterizing the Dysfunctional NK Cell: Assessing the Clinical Relevance of Exhaustion, Anergy, and Senescence
![Myeloid immunosuppression and immune checkpoints in the tumor microenvironment | Cellular & Molecular Immunology Myeloid immunosuppression and immune checkpoints in the tumor microenvironment | Cellular & Molecular Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41423-019-0306-1/MediaObjects/41423_2019_306_Fig1_HTML.png)
Myeloid immunosuppression and immune checkpoints in the tumor microenvironment | Cellular & Molecular Immunology
![First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation - ScienceDirect First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S000649712032173X-fx1.jpg)
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation - ScienceDirect
![The impact of "inflammaging", cellular senescence, oxidative stress and... | Download Scientific Diagram The impact of "inflammaging", cellular senescence, oxidative stress and... | Download Scientific Diagram](https://www.researchgate.net/publication/332651853/figure/fig2/AS:751602336034821@1556207369451/The-impact-of-inflammaging-cellular-senescence-oxidative-stress-and-CMV-on-the.png)
The impact of "inflammaging", cellular senescence, oxidative stress and... | Download Scientific Diagram
![A senescence stress secretome is a hallmark of therapy-related myeloid neoplasm stromal tissue occurring soon after cytotoxic exposure | Leukemia A senescence stress secretome is a hallmark of therapy-related myeloid neoplasm stromal tissue occurring soon after cytotoxic exposure | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41375-022-01686-y/MediaObjects/41375_2022_1686_Fig1_HTML.png)
A senescence stress secretome is a hallmark of therapy-related myeloid neoplasm stromal tissue occurring soon after cytotoxic exposure | Leukemia
![Immunotherapeutic HCW9218 augments anti-tumor activity of chemotherapy via NK cell-mediated reduction of therapy-induced senescent cells: Molecular Therapy Immunotherapeutic HCW9218 augments anti-tumor activity of chemotherapy via NK cell-mediated reduction of therapy-induced senescent cells: Molecular Therapy](https://www.cell.com/cms/attachment/e7318064-d2a9-425a-8648-9c0d015757b4/fx1_lrg.jpg)
Immunotherapeutic HCW9218 augments anti-tumor activity of chemotherapy via NK cell-mediated reduction of therapy-induced senescent cells: Molecular Therapy
![Frontiers | Natural Killer Cells in Myeloid Malignancies: Immune Surveillance, NK Cell Dysfunction, and Pharmacological Opportunities to Bolster the Endogenous NK Cells Frontiers | Natural Killer Cells in Myeloid Malignancies: Immune Surveillance, NK Cell Dysfunction, and Pharmacological Opportunities to Bolster the Endogenous NK Cells](https://www.frontiersin.org/files/Articles/489241/fimmu-10-02357-HTML/image_m/fimmu-10-02357-g001.jpg)